Elisabetta Leo

4.9k total citations · 1 hit paper
38 papers, 2.8k citations indexed

About

Elisabetta Leo is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Elisabetta Leo has authored 38 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 28 papers in Oncology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Elisabetta Leo's work include DNA Repair Mechanisms (19 papers), PARP inhibition in cancer therapy (17 papers) and Cancer therapeutics and mechanisms (6 papers). Elisabetta Leo is often cited by papers focused on DNA Repair Mechanisms (19 papers), PARP inhibition in cancer therapy (17 papers) and Cancer therapeutics and mechanisms (6 papers). Elisabetta Leo collaborates with scholars based in United Kingdom, United States and Italy. Elisabetta Leo's co-authors include Yves Pommier, Christophe Marchand, Hongliang Zhang, Gabriele Zoppoli, Alberto Ballestrero, Mirit I. Aladjem, William C. Reinhold, Sudhir Varma, Marie Regairaz and James H. Doroshow and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Elisabetta Leo

37 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs

2010 1.5k citations Yves Pommier, Elisabetta Leo et al. Chemistry & Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elisabetta Leo United Kingdom	22	2.2k	1.1k	362	255	221	38	2.8k
Andrzej Składanowski Poland	27	2.1k 1.0×	1.1k 1.0×	548 1.5×	283 1.1×	212 1.0×	62	2.9k
Joseph M. Covey United States	29	2.4k 1.1×	802 0.7×	320 0.9×	347 1.4×	253 1.1×	88	3.0k
Michelandrea De Cesare Italy	31	2.1k 0.9×	1.0k 0.9×	512 1.4×	267 1.0×	345 1.6×	94	3.0k
Alexandre E. Escargueil France	24	1.4k 0.7×	895 0.8×	230 0.6×	129 0.5×	315 1.4×	56	2.4k
Swee Y. Sharp United Kingdom	25	2.0k 0.9×	750 0.7×	417 1.2×	124 0.5×	198 0.9×	45	2.8k
Valentina Zuco Italy	27	1.8k 0.8×	579 0.5×	420 1.2×	176 0.7×	401 1.8×	70	2.4k
Yong‐Su Zhen China	26	1.5k 0.7×	658 0.6×	356 1.0×	100 0.4×	255 1.2×	154	2.3k
Peter Buhl Jensen Denmark	28	1.6k 0.7×	1.3k 1.1×	209 0.6×	225 0.9×	167 0.8×	103	2.5k
John K. Buolamwini United States	29	1.9k 0.9×	728 0.7×	755 2.1×	84 0.3×	243 1.1×	75	3.1k
Robert J. Hickey United States	31	2.7k 1.2×	854 0.8×	294 0.8×	102 0.4×	388 1.8×	103	3.3k

Countries citing papers authored by Elisabetta Leo

Since Specialization

Citations

This map shows the geographic impact of Elisabetta Leo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabetta Leo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabetta Leo more than expected).

Fields of papers citing papers by Elisabetta Leo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabetta Leo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabetta Leo. The network helps show where Elisabetta Leo may publish in the future.

Co-authorship network of co-authors of Elisabetta Leo

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabetta Leo. A scholar is included among the top collaborators of Elisabetta Leo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabetta Leo. Elisabetta Leo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Illuzzi, Giuditta, Alessandro Galbiati, Anna D. Staniszewska, et al.. (2025). Androgen receptor inhibition extends PARP inhibitor activity in prostate cancer models beyond BRCA mutations and defects in homologous recombination repair. NAR Cancer. 7(4). zcaf035–zcaf035.

Decio, Alessandra, Mark R. Albertella, Joanne Wilson, et al.. (2023). The PARP1 Inhibitor AZD5305 Impairs Ovarian Adenocarcinoma Progression and Visceral Metastases in Patient-derived Xenografts Alone and in Combination with Carboplatin. Cancer Research Communications. 3(3). 489–500. 9 indexed citations

Karmokar, Ankur, Adina Hughes, Zena Wilson, et al.. (2023). Relevance of ATM Status in Driving Sensitivity to DNA Damage Response Inhibitors in Patient-Derived Xenograft Models. Cancers. 15(16). 4195–4195. 4 indexed citations

Galbiati, Alessandro, Joshua Armenia, Giuditta Illuzzi, et al.. (2022). Drug–gene Interaction Screens Coupled to Tumor Data Analyses Identify the Most Clinically Relevant Cancer Vulnerabilities Driving Sensitivity to PARP Inhibition. Cancer Research Communications. 2(10). 1244–1254. 11 indexed citations

Willis, Sophie E., C Winkler, Martine P. Roudier, et al.. (2021). Retrospective analysis of Schlafen11 (SLFN11) to predict the outcomes to therapies affecting the DNA damage response. British Journal of Cancer. 125(12). 1666–1676. 31 indexed citations

Winkler, C, Matthew King, Domenico Ferraioli, et al.. (2021). SLFN11 captures cancer-immunity interactions associated with platinum sensitivity in high-grade serous ovarian cancer. JCI Insight. 6(18). 26 indexed citations

Winkler, C, Joshua Armenia, Gemma N. Jones, et al.. (2020). SLFN11 informs on standard of care and novel treatments in a wide range of cancer models. British Journal of Cancer. 124(5). 951–962. 51 indexed citations

Murai, Junko, Sai-Wen Tang, Elisabetta Leo, et al.. (2018). SLFN11 Blocks Stressed Replication Forks Independently of ATR. Molecular Cell. 69(3). 371–384.e6. 182 indexed citations

Ballestrero, Alberto, Davide Bedognetti, Domenico Ferraioli, et al.. (2017). Report on the first SLFN11 monothematic workshop: from function to role as a biomarker in cancer. Journal of Translational Medicine. 15(1). 199–199. 28 indexed citations

10.

Petrocchi, Alessia, Elisabetta Leo, Matthew M. Hamilton, et al.. (2016). Identification of potent and selective MTH1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 26(6). 1503–1507. 52 indexed citations

11.

Wang, Ruihong, Tyler Lahusen, Qiang Chen, et al.. (2014). SIRT1 Deacetylates TopBP1 and Modulates Intra-S-Phase Checkpoint and DNA Replication Origin Firing. International Journal of Biological Sciences. 10(10). 1193–1202. 37 indexed citations

12.

Fatoba, Samuel, Silvia Tognetti, Elisabetta Leo, et al.. (2013). Human SIRT1 regulates DNA binding and stability of the Mcm10 DNA replication factor via deacetylation. Nucleic Acids Research. 41(7). 4065–4079. 26 indexed citations

13.

Frontini, Mattia, Alexander Kukalev, Elisabetta Leo, et al.. (2012). The CDK Subunit CKS2 Counteracts CKS1 to Control Cyclin A/CDK2 Activity in Maintaining Replicative Fidelity and Neurodevelopment. Developmental Cell. 23(2). 356–370. 35 indexed citations

14.

Conti, Chiara, Elisabetta Leo, Gabriel S. Eichler, et al.. (2010). Inhibition of Histone Deacetylase in Cancer Cells Slows Down Replication Forks, Activates Dormant Origins, and Induces DNA Damage. Cancer Research. 70(11). 4470–4480. 126 indexed citations

15.

Xu, Dongyi, Parameswary A. Muniandy, Elisabetta Leo, et al.. (2010). Rif1 provides a new DNA‐binding interface for the Bloom syndrome complex to maintain normal replication. The EMBO Journal. 29(18). 3140–3155. 78 indexed citations

16.

Imbesi, S., Eustachio Nettis, Paola Lucia Minciullo, et al.. (2010). Hypersensitivity to tranexamic acid: a wide spectrum of adverse reactions. Pharmacy World & Science. 32(4). 416–419. 52 indexed citations

17.

Pommier, Yves, Elisabetta Leo, Hongliang Zhang, & Christophe Marchand. (2010). DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs. Chemistry & Biology. 17(5). 421–433. 1455 indexed citations breakdown →

18.

Visintin, Cristina, Elisabetta Leo, Sarah R. Kingsbury, et al.. (2008). Modular Assembly Using Sequential Palladium Coupling Gives Easy Access to the SMoC Class of Cellular Transporters. ChemBioChem. 9(11). 1787–1796. 8 indexed citations

19.

Laman, Heike, Sarah R. Kingsbury, Cristina Visintin, et al.. (2007). Small-molecule mimics of an α-helix for efficient transport of proteins into cells. Nature Methods. 4(2). 153–159. 59 indexed citations

20.

Sissi, Claudia, Elisabetta Leo, Stefano Moro, et al.. (2003). Antitumor AZA-anthrapyrazoles: biophysical and biochemical studies on 8- and 9-aza regioisomers. Biochemical Pharmacology. 67(4). 631–642. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact